Clinical Trial Update: Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly With Imatinib Mesylate (STI571) and Chemotherapy. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Imatinib Mesylate in combination with chemotherapy for elderly patients with Philadelphia chromosome-positive acute lymphoblastic leuke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• Imatinib mesylate (Imatinib)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Acute Lymphocytic Leukemia | Phase 2 | Status: UNKNOWN